These results indicated that TRPV4 activated the cdc42/N-wasp axis to regulate the protrusion formation and invasion of glioblastoma, whereas blocking TRPV4 with an inhibitor or shRNA effectively repressed glioblastoma invasion in vitro and in vivo (Fig. 8). The gene discussed is TRPV4; the disease is glioblastoma.